The Valley Desk

ArticleCancersPublished

A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in Lymphoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Cancers
Published
Subject terms
Tyrosine phosphorylation; In Silico Screening; Pi3p; Impdh2; Impdh Drug Discovery
PubMed ID
41154443
PubMed Central ID
PMC12563536
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal